You are here

  • Home
  • Archive
  • Volume 85, Issue 3
  • Aspirin for primary prevention of coronary heart disease: safety and absolute benefit related to coronary risk derived from meta-analysis of randomised trials

Citation Tools

Article menu

Download PDFPDF

Cardiovascular medicine
Aspirin for primary prevention of coronary heart disease: safety and absolute benefit related to coronary risk derived from meta-analysis of randomised trials

Download to a citation manager

Download the citation for this article by clicking on one of the following citation managers:

Cite this article as:
Sanmuganathan PS, Ghahramani P, Jackson PR, et al
Aspirin for primary prevention of coronary heart disease: safety and absolute benefit related to coronary risk derived from meta-analysis of randomised trials
Heart 2001;85:265-271.